Aptuit, Inc. has signed an agreement to acquire the assets and operations of EaglePicher Pharmaceutical Services (EPPS) as part of its plan to build capabilities in API development and drug substance manufacturing. Aptuit will expand its API and drug development offering, building state-of-the-art API development scale capabilities in the EaglePicher facilities and in new facilities around the globe. The acquisition is expected to close within 90 days. As part of the agreement, Aptuit will ...